ATF3 Demethylation Promotes the Transcription of ARL4C, Which Acts as a Tumor Suppressor in Human Breast Cancer
Liqi Li, 1, 2,* Rong-Mao Sun, 1,* Guo-Qin Jiang 1 1Department of Surgery, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215004, People’s Republic of China; 2Department of Thyroid Breast Surgery, Affiliated Hospital of Jiangnan University, Wuxi, Jiangsu 214062, Peo...
Main Authors: | Li L, Sun RM, Jiang GQ |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-04-01
|
Series: | OncoTargets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/atf3-demethylation-promotes-the-transcription-of-arl4c-which-acts-as-a-peer-reviewed-article-OTT |
Similar Items
-
Clinical relevance of ARF/ARL family genes and oncogenic function of ARL4C in endometrial cancer
by: Jiawen Zhang, et al.
Published: (2020-05-01) -
A QUASI ARL-UNBIASED U CONTROL CHART
by: Marco Antonio Argoti, et al.
Published: (2019-06-01) -
Activating transcription factor-2 (ATF2) is a key determinant of resistance to endocrine treatment in an in vitro model of breast cancer
by: Athina Giannoudis, et al.
Published: (2020-11-01) -
ARL3 is downregulated and acts as a prognostic biomarker in glioma
by: Yulin Wang, et al.
Published: (2019-06-01) -
Le décor architectonique de l’Arles antique
by: Bartette, Titien
Published: (2013)